Page last updated: 2024-09-04

cyc 202 and h 1152

cyc 202 has been researched along with h 1152 in 2 studies

Compound Research Comparison

Studies (cyc 202)	Trials (cyc 202)	Recent Studies (post-2010) (cyc 202)	Studies (h 1152)	Trials (h 1152)	Recent Studies (post-2010) (h 1152)
979	7	393	10	0	4

Protein Interaction Comparison

Protein	Taxonomy	h 1152 (IC50)
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	Bos taurus (cattle)	0.1035
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	Bos taurus (cattle)	0.1035
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	Bos taurus (cattle)	0.1035
Chain I, cAMP-dependent protein kinase inhibitor alpha	synthetic construct	0.1035
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	Bos taurus (cattle)	0.1035
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	Bos taurus (cattle)	0.1035
Chain I, cAMP-dependent protein kinase inhibitor alpha	synthetic construct	0.1035
Rho-associated protein kinase 2	Homo sapiens (human)	0.0097
cAMP-dependent protein kinase catalytic subunit alpha	Bos taurus (cattle)	0.3254
Rho-associated protein kinase 1	Homo sapiens (human)	0.005
Rho-associated protein kinase 2	Bos taurus (cattle)	0.3254
Leucine-rich repeat serine/threonine-protein kinase 2	Homo sapiens (human)	0.244

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N	1
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M	1

Other Studies

2 other study(ies) available for cyc 202 and h 1152

Article	Year
The selectivity of protein kinase inhibitors: a further update. The Biochemical journal, 2007, Dec-15, Volume: 408, Issue:3 Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera	2007
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51 Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases	2007

Article

Year

The selectivity of protein kinase inhibitors: a further update.

The Biochemical journal, 2007, Dec-15, Volume: 408, Issue:3

Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera

2007

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.

Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007